Table 3. Comparison between stem cells.
| Cell types | Category | Advantages | Disadvantages |
|---|---|---|---|
| ESCs | – | Unlimited proliferative ability Pluripotent |
Risk of teratoma formation (Ethical issue with the use of embryos for cell isolation The challenge to acquire patients’ own ESCs |
| iPSCs | – | Unlimited proliferative ability Pluripotent No ethical concern for tissue source |
Risk of teratoma formation Genotype change in the transfection process Low efficiency of the transfection process Less reported in tendon regeneration |
| MSCs | BMSCs ADSCs TDSCs |
Low cancerization rate Easily available tissue source for cell isolation No ethical concern for tissue source |
Senescence and loss of stem cell characteristics as the number of passages increase in vitro |
ESCs, embryonic stem cells; iPSCs, induced pluripotent stem cells; MSCs, mesenchymal stromal cells; BMSCs, bone marrow-derived mesenchymal stromal cells; ADSCs, adipose-derived stem cells; TDSCs, tendon-derived stem cells.